Call Options Transactions Made in Q4 2024 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q4 2024. The information is specifically focused on institutions that hold call options of Arbutus Biopharma Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
175KNew |
$557K - $735K
|
175K
$588K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-3.9K- 7.18% |
$12.4K - $16.4K
|
50.4K
$169K
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-127K- 34.21% |
$404K - $534K
|
245K
$822K
|
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
SELL
|
CALL |
-167K- 52.74% |
$532K - $703K
|
150K
$504K
|
|
|
Feb 14, 2025
Q4 2024
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-249K- 89.55% |
$793K - $1.05M
|
29.1K
$97.8K
|